InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 10.84
+0.49 (4.73%)
Jun 18, 2026, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 22.9 billion as of June 18, 2026. Its market cap has increased by 8.00% in one year.
Market Cap
22.90B
Enterprise Value
16.92B
Revenue
2.87B
Ranking
n/a
PE Ratio
21.97
Stock Price
10.84
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 22.90B, an increase of 86.50%. That is a compound annual growth rate of 10.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 22.90B | -3.33% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 38.85B |
| Shanghai Henlius Biotech | 32.53B |
| Shanghai Junshi Biosciences | 30.72B |
| Genscript Biotech | 25.12B |
| Metis TechBio | 16.60B |
| Keymed Biosciences | 16.59B |
| Duality Biotherapeutics | 16.42B |
| Zai Lab | 15.61B |